Dyskerin depletion increases VEGF mRNA internal ribosome entry site-mediated translation

Nucleic Acids Research

Volumn 41, Issue 17, 2013, Pages 8308-8318

  Rocchi, Laura ^a   Pacilli, Annalisa ^a   Sethi, Rajni ^b   Penzo, Marianna ^a   Schneider, Robert J ^b   Treré, Davide ^a   Brigotti, Maurizio ^a   Montanaro, Lorenzo ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DYSKERIN; MESSENGER RNA; VASCULOTROPIN;

ARTICLE; BREAST EPITHELIUM; CONTROLLED STUDY; DKC1 GENE; DOWN REGULATION; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC CODE; HUMAN; HUMAN CELL; IN VITRO STUDY; INTERNAL RIBOSOME ENTRY SITE; PRIMARY CELL CULTURE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN SECRETION; RNA INTERFERENCE; TRANSLATION INITIATION; UPREGULATION; VEGF GENE;

5' UNTRANSLATED REGIONS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; GENE KNOCKDOWN TECHNIQUES; HUMANS; NUCLEAR PROTEINS; PEPTIDE CHAIN INITIATION, TRANSLATIONAL; RNA INTERFERENCE; RNA, MESSENGER; RNA, VIRAL; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84884969772     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkt587     Document Type: Article

References (39)

1. Heiss,N.S., Knight,S.W., Vulliamy,T.J., Klauck,S.M., Wiemann,S., Mason,P.J., Poustka,A. and Dokal,I. (1998) X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nat. Genet., 19, 32-38. (Pubitemid 28242019)
2. Lafontaine,D.L., Bousquet-Antonelli,C., Henry,Y., Caizergues-Ferrer,M. and Tollervey,D. (1998) The box H+ACA snoRNAs carry Cbf5p, the putative rRNA pseudouridine synthase. Genes Dev., 12, 527-537. (Pubitemid 28101015)
3. Watkins,N.J. and Bohnsack,M.T. (2012) The box C/D and H/ACA snoRNPs: key players in the modification, processing and the dynamic folding of ribosomal RNA. Wiley Interdisci.p Rev. RNA, 3, 397-414.
4. Mitchell,J.R., Wood,E. and Collins,K. (1999) A telomerase component is defective in the human disease dyskeratosis congenital. Nature, 402, 551-555.
5. Knight,S.W., Heiss,N.S., Vulliamy,T.J., Greschner,S., Stavrides,G., Pai,G.S., Lestringant,G., Varma,N., Mason,P.J., Dokal,I. et al. (1999) X-linked dyskeratosis congenita is predominantly caused by missense mutations in the DKC1 gene. Am. J. Hum. Genet., 65, 50-58. (Pubitemid 30470448)
6. Dokai,I. (2000) Diskeratosis congenita in all its forms. Br. J. Haematol., 110, 768-779.
7. Ruggero,D., Grisendi,S., Piazza,F., Rego,E., Mari,F., Rao,P.H., Cordon-Cardo,C. and Pandolfi,P.P. (2003) Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification. Science, 299, 259-262. (Pubitemid 36125213)
8. Montanaro,L. (2010) Dyskerin and cancer: more than telomerase. The defect in mRNA translation helps in explaining how a proliferative defect leads to cancer. J. Pathol., 222, 345-349.
9. Yoon,A., Peng,G., Brandenburger,Y., Zollo,O., Xu,W., Rego,E. and Ruggero,D. (2006) Impaired control of IRES-mediated translation in X-linked dyskeratosis congenital. Science, 312, 902-906. (Pubitemid 43727321)
10. Montanaro,L., Calienni,M., Bertoni,S., Rocchi,L., Sansone,P., Storci,G., Santini,D., Ceccarelli,C., Taffurelli,M. et al. (2010) Novel dyskerin mediated mechanism of p53 inactivation through defective mRNA translation. Cancer Res., 70, 4767-4777.
11. Bellodi,C., Krasnykh,O., Haynes,N., Theodoropoulou,M., Peng,G., Montanaro,L. and Ruggero,D. (2010) Loss of function of the tumor suppressor DKC1 perturbs p27 translation control and contributes to pituitary tumorigenesis. Cancer Res., 70, 6026-6035.
12. Montanaro,L., Brigotti,M., Clohessy,J., Barbieri,S., Ceccarelli,C., Santini,D., Taffurelli,M., Calienni,M., Teruya-Feldstein,J., Trerè,D. et al. (2006) Dyskerin expression influences the level of ribosomal RNA pseudo-uridylation and telomerase RNA component in human breast cancer. J. Pathol., 210, 10-18. (Pubitemid 44288175)
13. Carmeliet,P. and Jain,R.K. (2000) Angiogenesis in cancer and other diseases. Nature, 407, 249-257.
14. Ferrara,N. (1999) Molecular and biological properties of vascular endothelial growth factor. J. Mol. Med., 77, 527-543. (Pubitemid 29426311)
15. Huez,I., Créancier,L., Audigier,S., Gensac,M.C., Prats,A.C. and Prats,H. (1998) Two independent internal ribosome entry sites are involved in translation initiation of vascular endothelial growth factor mRNA. Mol. Cell Biol., 18, 6178-6190. (Pubitemid 28500509)
16. Pinto,M.P., Badtke,M.M., Dudevoir,M.L., Harrell,J.C., Jacobsen,B.M. and Horwitz,K.B. (2010) Vascular Endothelial Growth Factor secreted by activated stroma enhances angiogenesis and hormone-independent growth of estrogen receptor-positive breast cancer. Cancer Res., 70, 2655-2664.
17. Bando,H. (2007) Vascular endothelial growth factor and bevacitumab in breast cancer. Breast Cancer, 14, 163-173.
18. Bert,A.G., Grépin,R., Vadas,M.A. and Goodall,G.J. (2006) Assessing IRES activity in the HIF-1alpha and other cellular 50 UTRs. RNA, 12, 1074-1083. (Pubitemid 43788125)
19. Bochkov,Y.A. and Palmenberg,A.C. (2006) Translational efficiency of EMCV IRES in bicistronic vectors is dependent upon IRES sequence and gene location. Biotechniques, 41, 283-290.
20. Van Eden,M.E., Byrd,M.P., Sherrill,K.W. and Lloyd,R.E. (2004) Demonstrating internal ribosome entry sites in eukaryotic mRNAs using stringent RNA test procedures. RNA, 10, 720-730. (Pubitemid 38405950)
21. Rubtsova,M.P., Sizova,D.V., Dmitriev,S.E., Ivanov,D.S., Prassolov,V.S. and Shatsky,I.N. (2003) Distinctive Properties of the 50-Untranslated Region of Human Hsp70 mRNA. J. Biol. Chem., 278, 22350-22356. (Pubitemid 36830284)
22. Thoma,C., Fraterman,S., Gentzel,M., Wilm,M. and Hentze,M.W. (2008) Translation initiation by the c-myc mRNA internal ribosome entry sequence and the poly(A) tail. RNA, 14, 1579-1589.
23. Chaudhuri,S., Vyas,K., Kapasi,P., Komar,A.A., Dinman,J.D., Barik,S. and Mazumder,B. (2007) Human ribosomal protein L13a is dispensable for canonical ribosome function but indispensable for efficient rRNA methylation. RNA, 13, 2224-2237. (Pubitemid 350127563)
24. Costa-Mattioli,M., Svitkin,Y. and Sonenberg,N. (2004) La autoantigen is necessary for optimal function of the poliovirus and hepatitis C virus internal ribosome entry site in vivo and in vitro. Mol. Cell. Biol., 24, 6861-6870. (Pubitemid 38944363)
25. Stein,I., Itin,A., Einat,P., Skaliter,R., Grossman,Z. and Keshet,E. (1998) Translation of vascular endothelial growth factor mRNA by internal ribosome entry: implications for translation under hypoxia. Mol. Cell. Biol., 18, 3112-3119. (Pubitemid 28240484)
26. Fong,B., Barkhoudarian,G., Pezeshkian,P., Parsa,A.T., Gopen,Q. and Yang,I. (2011) The molecular biology and novel treatments of vestibular schwannomas. J. Neurosurg., 115, 906-914.
27. Jack,K., Bellodi,C., Landry,D.M., Niederer,R.O., Meskauskas,A., Musalgaonkar,S., Kopmar,N., Krasnykh,O., Dean,A.M., Thompson,S.R. et al. (2011) rRNA pseudouridylation defects affect ribosomal ligand binding and translational fidelity from yeast to human cells. Mol. Cell, 18, 660-666.
28. King,H.A., Cobbold,L.C. and Willis,A.E. (2010) The role of IRES trans-acting factors in regulating translation initiation. Biochem. Soc. Trans., 38, 1581-1586.
29. Fitzgerald,K.D. and Semler,B.L. (2009) Bridging IRES elements in mRNAs to the eukaryotic translation apparatus. Biochim. Biophys. Acta, 1789, 518-528.
30. Silvera,D., Arju,R., Darvishian,F., Levine,P.H., Zolfaghari,L., Goldberg,J., Hochman,T., Formenti,S.C. and Schneider,R.J. (2009) Essential role for eIF4GI overexpression in the pathogenesis of inflammatory breast cancer. Nat. Cell Biol., 11, 903-908.
31. Jang,S.K. (2006) Internal initiation: IRES elements of picornaviruses and hepatitis c virus. Virus Res., 119, 2-15. (Pubitemid 43786257)
32. Bellodi,C., Kopmar,N. and Ruggero,D. (2010) Deregulation of oncogene-induced senescence and p53 translational control in X-linked dyskeratosis congenita. EMBO J., 29, 1865-1876.
33. Coradini,D., Biganzoli,E., Pellizzaro,C., Veneroni,S., Oriana,S., Ambrogi,F., Erdas,R., Boracchi,P., Daidone,M.G. and Marubini,E. (2003) Vascular endothelial growth factor in nodepositive breast cancer patients treated with adjuvant tamoxifen. Br. J. Cancer, 89, 268-270. (Pubitemid 36976314)
34. Xue,S. and Barna,M. (2012) Specialized ribosomes: a new frontier in gene regulation and organismal biology. Nat. Rev. Mol. Cell. Biol., 13, 355-369.
35. Angrisani,A., Turano,M., Paparo,L., Di Mauro,C. and Furia,M. (2011) A new human dyskerin isoform with cytoplasmic localization. Biochim. Biophys. Acta, 1810, 1361-1368.
36. Balvay,L., Soto-Rifo,R., Ricci,E.P., Decimo,D. and Ohlmann,T. (2009) Structural and functional diversity of viral IRESes. Biochim. Biophys. Acta, 1789, 542-557.
37. Komar,A.A. and Hatzoglou,M. (2011) Cellular IRES-mediated translation. The war of ITAFs in pathophysiological states. Cell Cycle, 10, 229-240.
38. Basu,A., Das,P., Chaudhuri,S., Bevilacqua,E., Andrews,J., Barik,S., Hatzoglou,M., Komar,A.A. and Mazumder,B. (2011) Requirement of rRNA methylation for 80S ribosome assembly on a cohort of cellular internal ribosome entry sites. Mol. Cell Biol., 31, 4482-4499.
39. Gingras,A.C., Raught,B. and Sonenberg,N. (2001) Regulation of translation initiation by FRAP/mTOR. Genes Dev., 15, 807-826. (Pubitemid 32295062)